Glenn H. Schiffman - 17 Jun 2025 Form 4 Insider Report for Angi Inc. (ANGI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Jun 2025, 16:11:01 UTC
Prior SEC filing
21 Apr 2025
Next SEC filing
23 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Shannon M. Shaw as Attorney-in-Fact for Glenn H. Schiffman

Key filing fact

Glenn H. Schiffman filed Form 4 for Angi Inc. (ANGI) on 20 Jun 2025.

Key facts

  • This page summarizes Glenn H. Schiffman's Form 4 filing for Angi Inc. (ANGI).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 20 Jun 2025, 16:11.

Change

  • Previous filing in this sequence was filed on 21 Apr 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001670982 Primary reporting owner

Schiffman Glenn

Relationship
Director
Address
C/O ANGI INC., 3601 WALNUT STREET, SUITE 700, DENVER
Signature
Shannon M. Shaw as Attorney-in-Fact for Glenn H. Schiffman
Signature date
20 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGI holding

Class A Common Stock, par value $0.001

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
34,014
Date
17 Jun 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANGI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+16,436
Change %
Price
$0.000000
Shares after
16,436
Date
17 Jun 2025
Ownership
Direct
Underlying class
Class A Common Stock, par value $0.001
Underlying amount
16,436
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Effective on March 24, 2025, ANGI effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Footnote F2

On March 31, 2025, the Reporting Person received 32,156 shares of ANGI Class A common stock in connection with the completion of the spin-off by IAC Inc. ("IAC") of ANGI by means of a special dividend (the "Distribution") of all of the shares of Class A Common Stock then held by IAC to holders of its common stock and Class B common stock (together, the "IAC Stock"). This special dividend was paid through the distribution of 42,080,232 shares of Class A Common Stock on March 31, 2025 to holders of record of IAC Stock as of the close of business on March 25, 2025 (the "Record Date"), on a pro rata basis. Holders of IAC Stock as of the Record Date received 0.5251 shares of Class A Common Stock for each share of IAC Stock then held. This transaction is exempt under Rule 16a-9(a).

Footnote F3

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock.

Footnote F4

Represents RSUs that vest in equal installments over three years on the anniversary of the grant date (June 17, 2025), subject to continued service. Pursuant to the reporting person's deferral election, any vested RSUs will be settled in a lump sum following termination of service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .